274
Surv Ophthalmol 30(4) January-February
1986
CURRENT OPHTHALMOLOGY
Comment This paper marks an important contribution to our current understanding of the mechanism by which transient obscurations (TOV) occur. The authors report the obscurations encountered in four patients. Three of the patients had non-papilledematous elevation of the optic disc caused by a variety of conditions and included chronic uveitis with passive disc edema, perioptic meningioma, and optic nerve drusen. Another patient with a large posterior pole coloboma and no disc elevation had symptoms compatible with TOV. That papilledema alone is not the only factor accounting for TOV is quite true. Our first experience with such a patient occurred in an individual with bilateral disc edema caused by xanthomatous orbital tumors that encased the optic nerves. It seems obvious that TOV must represent the clinical manifestations of a transient compromise of vascular function within the optic nerve head. The postural effects on TOV frequency are probably the result of altered central venous pressure with consequent secondary effects on venous flow within the orbit and optic nerve. One word of caution. The patient with a visual loss attributed to optic nerve drusen experienced some attacks ofvisual loss that lasted as long as live minutes. Although disc congestion caused by a drusen might be the only explanation for his complaints, I was surprised that the authors did not mention that specific testing of carotid patency was done and.was normal. Transient ischemic attacks of carotid origin often cause bouts of visual loss lasting as long as five minutes. This patient’s attacks were not precipitated by postural changes, as was the case in the other three patients. Exclusion of other factors besides drusen that could be causing a relative impairment of the perfusion of the optic disc in an elderly patient must be considered. JOHN MCCFLARY III, M.D. HOUSTON, TEXAS
Doyne Lecture: Heterochromic
104:219-231,
Iridocyclitis,
by G. R. O’Connor.
Tmns Ophthalmol Sot UK
1985
Fuchs’ heterochromic iridocyclitis is a rare but significant cause ofvisual impairment. This form of uveitis is misdiagnosed more than any other disorder in the entire field of uveitis. This is particularly true among brown-eyed individuals in whom gross heterochromia may not be diagnosed for many years. The clinical presentation of Fuchs’ heterochromic iridocyclitis may include a number of general unrecognized variants among which are Koeppe nodules, transient synechia formations, and blood-filled cysts. Recently, the relationship of heterochromic iridocyclitis to posterior inflammatory lesions, such as those of toxoplasmosis, have been explored. Although the disease was once thought to be a degenerative or tropic disorder, current investigations reveal that it is a true inflammation of immunologic origin. The disorder may be related to a depression of suppressor T-cell activity. The etiology of the disease is still obscure, but in some cases an association with simple heterochromia has been found among families in whom multiple members are affected by either simple heterochromia or Fuchs’ heterochromic iridocyclitis. Corticosteroid treatment of Fuchs’ heterochromic iridocyclitis is not effective and should be reserved for those patients in whom inflammatory products obstruct the visual axis. Most patients should be treated by observation alone. Cataract and glaucoma are the most important complications. Treatment of the glaucoma is particularly difftcult and often unsuccessful. (Author’s address: Dr. G. Richard O’Connor, 22 Wray Ave., Sausolito, CA 94965).
Comment As a Doyne lecturer for 1984, Dr. O’Connor has presented an excellent review about a disease which remains enigmatic in ophthalmology. Heterochromic iridocyclitis, described in Fuchs’ classical paper of 1906, is a condition affecting only one eye in 90% of the cases and rarely observed. It may be estimated that, in Belgium, an ophthalmologist with a full-time clinical practice might detect one case every two or three years. For the members of the International Uveitis Study Group (IUSG) Fuchs’ heterochromic iridocyclitis (FHI) affects 3.2% (+ 2.45%) of the patients examined in 1982 in their uveitis clinics. As Dr. O’Connor points out, the diagnosis of FHI is often diflicult. This is because the different clinical
275
CURRENTOPHTHALMOLOGY signs are not always about
550 patients
scattered
present
at the same
with FHI,
on the whole posterior
secondary
to stromal
atrophy
time.
the most
According
frequently
side of the cornea and defects
to the information
observed (95.7%
signs
of the cases);
in the posterior
given by the IUSG
are (1) the typical
pigment
keratic
(2) hypochromia
members
precipitates,
of the iris, which is
epithelium (86.5% of the cases); (3) and (4) filiform hemorrhage following
cataract starting under the posterior capsule of the lens (83.6%) puncture of the anterior chamber (86.7% of the 75 cases examined by two IUSG members). In our experience, the cases without heterochromia of the iris are bilateral cases or dark-eyed patients. Moreover, cataract, occurring
later
during
Etiopathogeny theories
the development
of FHI
have allowed
would first inhibit
of the disease,
has been at the origin
a better
normal
understanding
development
eye would
respond
connection
has been established
is generally
of many
of the disease.
of the uveal pigment
to the pathologic
agent
between
FHI
not detectable
controversies. Fuchs
himself
in very young
sympathetic
thought
mild
disease.
chronic
involved
heterochromia.
iridocyclitis.
However,
patients.
nor hereditary
that the factors
with, as a consequence,
by an unusually and a systemic
Neither
Later
Up
some patients
the
to now,
with FHI
no
were
recently reported to have associated retinal lesions of the type found in ocular toxoplasmosis. These lesions were located in the eye with FHI, in the fellow eye or in both eyes. They could be secondary to the agent responsible
for iridocyclitis
Immunological in the aqueous intraocular against
changes humor
origin
a bacterial
immune
reactions
correspond
or to alteration were recently
from
as discussed
in immunological
28 of our 35 patients elsewhere,
to immune
complexes
FHI
examined.
They This
could be the expression
or a viral agent or against in the eyes with
response.
found in eyes with FHI.
the ocular
consist
most
of intraocular
immune
reactions
Another
in the aqueous
in 22 of our 28 cases examined
abundance
of IgG,
tissues themselves.
is the detection,
of a relative
abundance
of IgG
probably
proof of the existence
humor,
of factors
and in approximately
35%
of
directed
assumed
of to
of Dr. O’Con-
nor’s cases. These factors are probably of intraocular origin since they were detected in the aqueous humor and not in the serum, or at the same titer in both fluids, although there were large differences in their protein contents. Dr. O’Connor to a depression
evoked in his lecture of suppressor
concerning
the suppressor
Ophthalmol
(&$$d)
163:52,
even if this mechanism The possible
T-cells.
the possibility
that these intraocular
This fascinating
hypothesis,
immune
reactions
could be related
based on a work by Murray
and Dinning
activities of T-lymphocytes of blood from patients with FHI (Murray PI, et al: Acta origin. However, 1984), would have to be confirmed for the T-cells of intraocular
was confirmed,
role of viral agents
the nature
would
of the agent responsible
for FHI
would remain
unknown.
have to be studied.
To summarize, it seems obvious that FHI is an immunological disease which could be secondary to a local infection of viral or bacterial origin. Then there would be a relationship between the modern immunological theory
and the Fuchs’ theory
based
on a local infection. JEAN-PAUL DERNOUCHAMPS, M.D. BRUSSELS, BELGIUM
Evidence of Extraocular Muscle Restriction in Autoimmune Thyroid Disease, by G. T. Gamblin, P. Galentine, B. Chernow, et al. J Clin Endocrinol Metabol 61: 167-171, 1985 Patients
with Graves’ ophthalmopathy
frequently
have transient
positional
changes
in intraocular
sure, especially on upgaze, a phenomenon attributed to compression of the globe by the opposing extraocular muscles. In this study, the authors compared a group of patients with Graves’ thyroid
pres-
inelastic ophthal-
mopathy, Hashimoto’s thyroiditis, subacute thyroiditis and normal patients. Abnormalities of elevation in the intraocular pressure were sought at both 15” and 25” of upgaze. At 15” upgaze, intraocular pressure abnormalities occurred in 25% of patients with Graves’ thyroid ophthalmopathy and 13% of patients with Hashimoto’s thyroiditis. At 25” upgaze, these figures rose to 54% for Graves’ thyroid ophthalmopathy and 37% in Hashimoto’s thyroiditis. Only one of 25 normal subjects had an elevation of intraocular pressure changes on upgaze, as did one patient with silent thyroiditis, but no patients with subacute thyroiditis exhibited intraocular pressure elevations. The authors suggest that these data document the frequent presence of extraocular muscle restriction in patients with a history of Hashimoto’s thyroiditis as well as in patients with a history of Graves’ thyroid